Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meshach Asare-Werehene

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Scientific Reports|October 22, 2025
Global DNA methylation signatures associated with chemoresistance and poor prognosis of high grade serous ovarian cancerHafiza Bushra Manzoor, Melisa Acun, Hamed Yasavoli-Sharahi, et al.
Scientific Reports|September 28, 2019
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian CancerMeshach Asare-Werehene, Laudine Communal, Euridice Carmona, et al.
Journal of Ovarian Research|January 15, 2023
Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolinEmma Gerber, Meshach Asare-Werehene, Arkadiy Reunov, et al.
Clinical Chemistry and Laboratory Medicine|December 16, 2025
Hook effect for ferritin immunoassays: implications for clinical practiceMeshach Asare-Werehene, Qiu Yi Shao, Felix Leung, et al.
Frontiers in Immunology|July 29, 2025
Spotlight on nuclear PD-L1 in ovarian cancer chemoresistance: hidden but mightyMeshach Asare-Werehene, Arvin Zaker, Shivanshi Tripathi, et al.
Cancer Research|July 10, 2020
Plasma Gelsolin Inhibits CD8<sup>+</sup> T-cell Function and Regulates Glutathione Production to Confer Chemoresistance in Ovarian CancerMeshach Asare-Werehene, Laudine Communal, Euridice Carmona, et al.
The Journal of Applied Laboratory Medicine|January 23, 2026
Validation of Plasma Free Hemoglobin Testing for Extracorporeal Membrane Oxygenation (ECMO) PatientsMeshach Asare-Werehene, Mary Kathryn Bohn, Bianca Wan, et al.
Frontiers in Immunology|September 23, 2022
Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomesMeshach Asare-Werehene, Michaeline McGuinty, Agatha Vranjkovic, et al.
Cancers|May 13, 2023
The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian CancerMeshach Asare-Werehene, Robert A Hunter, Emma Gerber, et al.
Cancers|February 25, 2022
Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage SubtypesMeshach Asare-Werehene, Hideaki Tsuyoshi, Huilin Zhang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scientific Reports|October 22, 2025
Global DNA methylation signatures associated with chemoresistance and poor prognosis of high grade serous ovarian cancerHafiza Bushra Manzoor, Melisa Acun, Hamed Yasavoli-Sharahi, et al.
Scientific Reports|September 28, 2019
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian CancerMeshach Asare-Werehene, Laudine Communal, Euridice Carmona, et al.
Journal of Ovarian Research|January 15, 2023
Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolinEmma Gerber, Meshach Asare-Werehene, Arkadiy Reunov, et al.
Clinical Chemistry and Laboratory Medicine|December 16, 2025
Hook effect for ferritin immunoassays: implications for clinical practiceMeshach Asare-Werehene, Qiu Yi Shao, Felix Leung, et al.
Frontiers in Immunology|July 29, 2025
Spotlight on nuclear PD-L1 in ovarian cancer chemoresistance: hidden but mightyMeshach Asare-Werehene, Arvin Zaker, Shivanshi Tripathi, et al.
Cancer Research|July 10, 2020
Plasma Gelsolin Inhibits CD8<sup>+</sup> T-cell Function and Regulates Glutathione Production to Confer Chemoresistance in Ovarian CancerMeshach Asare-Werehene, Laudine Communal, Euridice Carmona, et al.
The Journal of Applied Laboratory Medicine|January 23, 2026
Validation of Plasma Free Hemoglobin Testing for Extracorporeal Membrane Oxygenation (ECMO) PatientsMeshach Asare-Werehene, Mary Kathryn Bohn, Bianca Wan, et al.
Frontiers in Immunology|September 23, 2022
Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomesMeshach Asare-Werehene, Michaeline McGuinty, Agatha Vranjkovic, et al.
Cancers|May 13, 2023
The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian CancerMeshach Asare-Werehene, Robert A Hunter, Emma Gerber, et al.
Cancers|February 25, 2022
Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage SubtypesMeshach Asare-Werehene, Hideaki Tsuyoshi, Huilin Zhang, et al.
Pageof 3